Rossari Historical Balance Sheet
ROSSARI Stock | 826.15 18.40 2.18% |
Trend analysis of Rossari Biotech Limited balance sheet accounts such as Total Stockholder Equity of 11 B, Other Liab of 1.9 B, Net Tangible Assets of 6.6 B or Property Plant And Equipment Net of 2.1 B provides information on Rossari Biotech's total assets, liabilities, and equity, which is the actual value of Rossari Biotech to its prevalent stockholders. By breaking down trends over time using Rossari Biotech balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Rossari Biotech latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Rossari Biotech is a good buy for the upcoming year.
Rossari Biotech Inventory |
|
Rossari |
About Rossari Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Rossari Biotech at a specified time, usually calculated after every quarter, six months, or one year. Rossari Biotech Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Rossari Biotech and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Rossari currently owns. An asset can also be divided into two categories, current and non-current.
Rossari Biotech Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Rossari Biotech assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Rossari Biotech books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Rossari Biotech balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Rossari Biotech Limited are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Intangible Assets
Non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value.Most accounts from Rossari Biotech's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Rossari Biotech current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rossari Biotech Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. As of now, Rossari Biotech's Other Liabilities is increasing as compared to previous years. The Rossari Biotech's current Net Tangible Assets is estimated to increase to about 6.6 B, while Total Assets are projected to decrease to under 7.9 B.
2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 739.3M | 1.2B | 1.2B | Total Assets | 13.7B | 15.7B | 7.9B |
Rossari Biotech balance sheet Correlations
Click cells to compare fundamentals
Rossari Biotech Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Rossari Biotech balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 4.7B | 5.6B | 12.6B | 13.7B | 15.7B | 7.9B | |
Short Long Term Debt Total | 45.3M | 669.3M | 84.3M | 739.3M | 1.2B | 1.2B | |
Other Current Liab | 111.1M | 190.7M | 157.1M | 1.1B | 1.3B | 1.4B | |
Total Current Liabilities | 1.5B | 1.5B | 2.9B | 3.5B | 4.2B | 2.2B | |
Total Stockholder Equity | 2.9B | 4.1B | 8.1B | 9.2B | 10.5B | 11.0B | |
Other Liab | 35.6M | 21.7M | 23.9M | 1.6B | 1.8B | 1.9B | |
Net Tangible Assets | 1.2B | 2.8B | 4.0B | 5.4B | 6.3B | 6.6B | |
Property Plant And Equipment Net | 1.1B | 1.7B | 3.5B | 3.3B | 4.3B | 2.1B | |
Current Deferred Revenue | (329.7M) | 53.9M | 903.5M | 1.2B | 125.1M | 118.8M | |
Net Debt | 377.2M | (152.1M) | (290.5M) | 41.0M | 936.2M | 983.0M | |
Retained Earnings | 1.6B | 2.4B | 3.3B | 4.4B | 5.6B | 5.9B | |
Accounts Payable | 970.0M | 1.3B | 1.9B | 1.8B | 2.2B | 1.4B | |
Cash | 292.1M | 152.1M | 374.8M | 698.3M | 251.7M | 254.9M | |
Non Current Assets Total | 1.5B | 2.1B | 6.5B | 6.5B | 7.3B | 7.7B | |
Non Currrent Assets Other | 255.1M | 55.9M | 130.5M | 183.4M | 104.4M | 122.5M | |
Other Assets | 130.3M | 255.6M | 58.9M | 144.0M | 165.6M | 114.4M | |
Cash And Short Term Investments | 1.4B | 883.6M | 644.3M | 1.5B | 667.9M | 732.6M | |
Net Receivables | 941.4M | 1.5B | 3.0B | (23.4M) | 4.3B | 4.5B | |
Common Stock Shares Outstanding | 49.3M | 51.9M | 55.2M | 55.4M | 55.3M | 53.1M | |
Short Term Investments | 1.2B | 731.5M | 269.5M | 819.5M | 416.2M | 477.7M | |
Liabilities And Stockholders Equity | 4.7B | 5.6B | 12.6B | 13.7B | 15.7B | 7.9B | |
Non Current Liabilities Total | 361.3M | 23.9M | 1.6B | 1.1B | 996.9M | 568.9M | |
Inventory | 581.7M | 953.5M | 1.9B | 1.9B | 2.8B | 3.0B | |
Other Current Assets | 290.8M | 242.2M | 500.8M | 3.8B | 4.9B | 5.2B | |
Other Stockholder Equity | 1.2B | (2.5B) | 4.6B | 4.6B | 4.7B | 4.9B | |
Total Liab | 1.8B | 1.5B | 4.5B | 4.5B | 5.2B | 2.8B | |
Total Current Assets | 3.3B | 3.5B | 6.1B | 7.2B | 8.4B | 4.4B | |
Short Term Debt | 313.4M | 53.9M | (714.9M) | 390.0M | 745.6M | 782.9M | |
Intangible Assets | 47.7M | 107.6M | 1.7B | 1.5B | 1.4B | 1.5B | |
Common Stock | 101.5M | 103.9M | 110.1M | 110.3M | 110.5M | 91.9M | |
Property Plant Equipment | 708.6M | 1.1B | 1.7B | 3.5B | 4.0B | 4.2B | |
Long Term Debt | 6.7M | 339.6M | 0.0 | 349.3M | 333.2M | 349.9M | |
Net Invested Capital | 3.5B | 4.1B | 8.1B | 9.9B | 11.5B | 6.2B | |
Short Long Term Debt | 329.7M | 0.0 | 84.3M | 390.0M | 725.0M | 761.3M | |
Net Working Capital | 1.8B | 2.0B | 3.1B | 3.7B | 4.2B | 2.5B | |
Capital Stock | 101.5M | 103.9M | 110.1M | 110.3M | 110.5M | 106.4M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Rossari Stock
Balance Sheet is a snapshot of the financial position of Rossari Biotech at a specified time, usually calculated after every quarter, six months, or one year. Rossari Biotech Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Rossari Biotech and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Rossari currently owns. An asset can also be divided into two categories, current and non-current.